Cable-piliated Burkholderia cepacia binds to cytokeratin 13 of epithelial cells

Infection and Immunity

Volumn 68, Issue 4, 2000, Pages 1787-1795

  Sajjan, Umadevi S ^a   Sylvester, Francisco A ^b   Forstner, Janet F ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b Farmington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIUM ADHERENCE; BACTERIUM PILUS; BURKHOLDERIA CEPACIA; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION;

AMINO ACID SEQUENCE; BACTERIAL ADHESION; BRONCHI; BURKHOLDERIA CEPACIA; CELLS, CULTURED; CYSTIC FIBROSIS; CYTOSKELETON; CYTOSOL; EPITHELIAL CELLS; HUMANS; KERATINS; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; RECEPTORS, IMMUNOLOGIC; TUMOR CELLS, CULTURED;

EID: 0034028549     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.4.1787-1795.2000     Document Type: Article

References (51)

1. Blobel, G. A., R. Moll, W. W. Franke, and I. Vogt-Moykopf. 1984. Cytokeratins in normal lung and lung carcinomas. Virchows Arch. B Cell Pathol. 45:407-429.
2. Broers, J. L., D. N. Carney, M. Klein Rot, G. Schaart, E. B. Lane, G. P. Vooijs, and F. C. Ramaekers. 1986. Intermediate filament proteins in classic and variant types of small cell lung carcinoma cell lines: a biochemical and immunochemical analysis using a panel of monoclonal and polyclonal antibodies. J. Cell Sci. 83:37-60.
3. Burns, J. L., C. D. Wardsworth, J. J. Barry, and C. P. Goodall. 1996. Nucleotide sequence analysis of a gene from Burkholderia cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance. Antimicrob. Agents Chemother. 40:307-313.
4. Darling, P., M. Chan, A. D. Cox, and P. A. Sokol. 1998. Siderophore production by cystic fibrosis isolates of Burkholderia cepacia. Infect. Immun. 66:874-877.
5. Diaz, L. A., S. A. P. Sampaio, C. R. Martins, E. A. Rivitti, M. L. Macca, J. T. Roscoe, Y. Takahashi, R. S. Labib, H. P. Patel, D. F. Mutasim, E. M. Kugan, and G. J. Anhalt. 1987. An autoantibody in pemphigus serum, specific for the 59 KD keratin, selectively binds the surface of keratinocytes: evidence for an extracellular keratin domain. J. Investig. Dermatol. 89:287-295.
6. Doorbar, J., S. Ely, J. Sterling, C. McLean, and L. Crawford. 1991. Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of epithelial cell intermediate filament network. Nature 352:824-827.
7. Falk, P., K. A. Roth, T. Boren, T. U. Westblom, and J. I. Gordon. 1993. An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the human gastric epithelium. Proc. Natl. Acad. Sci. USA 90:2035-2039.
8. Franke, W. W., D. L. Schiller, R. Moll, S. Winter, E. Schmid, I. Engelbrecht, H. Denk, R. Krepler, and B. Platzer. 1981. Diversity of cytokeratins. Differentiation specific expression of cytokeratin polypeptides in epithelial cells and tissues. J. Mol. Biol. 153:933-959.
9. Godfroid, E., M. Geuskens, T. Dupressoir, I. Parent, and C. Szpirer. 1991. Cytokeratins are exposed on the outer surface of established human mammary carcinoma cells. J. Cell Sci. 99:565-607.
10. Goding, J. W. (ed.). 1986. Monoclonal antibodies: principles and practice. 2nd ed. Academic Press, Inc., New York, N.Y.
11. Govan, J. R. W., and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574.
12. Govan, J. R. W., J. E. Hughes, and P. Vandamme. 1996. Burkholderia cepacia: medical, taxonomic and ecological issues. J. Med. Microbiol. 45:395-407.
13. Grace, M. P., K. H. Kim, L. D. True, and E. Fuchs. 1985. Keratin expression in normal esophageal epithelium and squamous cell carcinoma of the esophagus. Cancer Res. 45:841-846.
14. Hembrough, T. A., J. Vasudevan, M. M. Allietta, W. F. Glass II, and S. L. Gonias. 1995. A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines. J. Cell Sci. 108:1071-1082.
15. Hughes, J. E., J. Stewart, G. R. Barclay, and J. R. Govan. 1997. Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia. Infect. Immun. 65:4281-4287.
16. Hutchison, M. L., I. R. Poxton, and J. R. Govan. 1998. Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes. Infect. Immun. 66:2033-2039.
17. Johansen, H. K., T. A. Kovesi, C. Koch, M. Corey, N. Hoiby, and H. Levison. 1998. Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen. Pediatr. Pulmonol. 26:89-96.
18. Jones, J. C., and K. J. Green. 1991. Intermediate filament-plasma membrane interactions. Curr. Opin. Cell Biol. 3:127-132.
19. Lacy, D., D. Spencer, A. Goldstein, P. Weller, and P. Darbyshire. 1993. Chronic granulomatous disease presenting in childhood with Pseudomonas cepacia septicaemia. J. Infect. 27:301-304.
20. Ledson, M. J., M. J. Gallagher, J. E. Corkill, C. A. Hart, and M. J. Walshaw. 1998. Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax 53:432-436.
21. Leube, R. E., and T. J. Rustad. 1991. Squamous cell metaplasia in the human lung: molecular characteristics of epithelial stratification. Virchows Arch. B Cell Pathol. 61:227-253.
22. LiPuma, J. J. 1998. Burkholderia cepacia. Management issues and new insights. Clin. Chest Med. 19:473-86.
23. Lonon, M. K., D. E. Woods, and D. C. Straus. 1988. Production of lipase by clinical isolates of Pseudomonas cepacia. J. Clin. Microbiol. 26:976-984.
24. Mahenthiralingam, E., M. E. Campbell, D. A. Henry, and D. P. Speert. 1996. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J. Clin. Microbiol. 34:2914-2920.
25. McKevitt, A. I., S. Bajaksouzian, J. D. Klinger, and D. E. Woods. 1989. Purification and characterization of an extracellular protease from Pseudomonas cepacia. Infect. Immun. 57:771-778.
26. Moll, R., W. W. Franke, D. L. Schiller, B. Geiger, and R. Krepler. 1982. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24.
27. Morgan, P. R., I. M. Leigh, P. E. Purkis, I. D. Gardner, G. N. P. van Muijen, and E. B. Lane. 1987. Site variation in keratin expression in human oral epithelia - an immunocytochemical study of individual keratins. Epithelia 1:31-43.
28. Moss-Salentijn, L., and M. Hendricks-Klyvert (ed.). 1990. Dental and oral tissues: an introduction, 3rd ed. Lea & Febiger, Philadelphia, Pa.
29. Nagle, R. B., R. Moll, H. Weidauer, H. Nemetschek, and W. W. Franke. 1982. Different patterns of cytokeratin expression in the normal epithelia of the upper respiratory tract. Differentiation 30:130-140.
30. Nelson, W. G., and T.-T. Sun. 1983. The 50- and 58-kilodalton keratin classes as molecular markers for stratified squamous epithelia: cell culture studies. J. Cell Biol. 97:244-251.
31. Pitt, T. L., M. E. Kaufmann, P. S. Patel, L. C. Benge, S. Gaskin, and D. M. Livermore. 1996. Type characterization and antibiotic susceptibility of Burkholderia cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J. Med. Microbiol. 44:203-210.
32. Roger, P., E. Puchelle, O. Bajolet-Laudinat, J. M. Tournier, C. Debordeaux, M. C. Plotkowski, J. H. Cohen, D. Sheppard, and S. de Bentzmann. 1999. Fibronectin and α5β1 integrin mediate binding of Pseudomonas aeruginosa to repairing airway epithelium. Eur. Respir. J. 13:1301-1309.
33. Rosenfeld, M., R. Davis, S. FitzSimmons, M. Pepe, and B. Ramsey. 1997. Gender gap in cystic fibrosis mortality. Am. J. Epidemiol. 145:794-803.
34. Safiejko-Mroczka, B., and P. B. Bell. 1996. Bifunctional protein cross-linking reagents improve labeling of cytoskeletal proteins for qualitative and quantitative fluorescence microscopy. J. Histochem. Cytochem. 44:641-656.
35. Sajjan, U. S., M. Corey, M. Karmali, and J. F. Forstner. 1991. Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J. Clin. Investig. 89:648-656.
36. Sajjan, U. S., and J. F. Forstner. 1992. Identification of the mucin-binding adhesin of isolated Pseudomonas cepacia from patients with cystic fibrosis. Infect. Immun. 60:1434-1440.
37. Sajjan, U. S., and J. F. Forstner. 1993. Role of a 22-kilodalton pilin protein in binding of Pseudomonas cepacia to buccal epithelial cells. Infect. Immun. 61:3157-3163.
38. Sajjan, U. S., L. Sun, R. Goldstein, and J. F. Forstner. 1995. Cable (cb1) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J. Bacteriol. 177:1030-1038.
39. Schulz, P., E. Wachter, K. Hochstrasser, A. G. Wild, and D. Mischke. 1989. Sequence of a human keratin 13 specific cDNA encompassing coil 1B through the 3′ end. Biochem. Biophys. Res. Commun. 162:1522-1527.
40. Sharpe, A. H., L. B. Chen, J. R. Murphy, and B. N. Fields. 1980. Specific disruption of vimentin filament organization in monkey kidney CV-1 cells by diphtheria toxin, exotoxin A, and cycloheximide. Proc. Natl. Acad. Sci. USA 77:7267-7271.
41. Smack, D. P., B. P. Korge, and W. D. James. 1994. Keratin and keratinization. J. Am. Acad. Dermatol. 30:85-102.
42. Stosiek, P., M. Kasper, and R. Moll. 1992. Changes in cytokeratin expression accompany squamous metaplasia of the human respiratory epithelium. Virchows Arch. A Pathol. Anat. 421:133-141.
43. + Pseudomonas (Burkholderia) cepacia causing epidemics in North America and Britain. Nat. Med. 1:661-666.
44. Sylvester, F. A., U. S. Sajjan, and J. F. Forstner. 1996. Burkholderia (basonym Pseudomonas) cepacia binding to lipid receptors. Infect. Immun. 64:1420-1425.
45. van Muijen, G. N. P., D. J. Ruiter, W. W. Franke, T. Achtstatter, W. H. B. Haasnoot, M. Ponec, and S. O. Warnaar. 1986. Cell type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins nos. 4 and 13. Exp. Cell Res. 162:97-113.
46. Vandamme, P., B. Holmes, M. Vancanneyt, T. Coenye, B. Hoste, R. Coopman, H. Revets, S. Lauwers, M. Gillis, K. Kersters, and J. R. W. Govan. 1997. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. Int. J. Syst. Bacteriol. 47:1188-1200.
47. White, E., and R. Cipriani. 1990. Role of adenovirus E1B proteins in transformation: altered organization of intermediate filaments in transformed cells that express the 19-kilodalton protein. Mol. Cell. Biol. 10:120-130.
48. Whiteford, M. L., J. D. Wilkinson, J. H. McColl, F. M. Conlon, J. R. Michie, T. J. Evans, and J. Y. Paton. 1995. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Thorax 50:1194-1198.
49. Wu, X., M. Kurpakus, and L. D. Hazlett. 1996. Some P. aeruginosa pilus-binding proteins of human corneal epithelium are cytokeratins. Curr. Eye Res. 15:782-791.
50. Zughaier, S. M., H. C. Ryley, and S. K. Jackson. 1999. Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenostrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes. Infect. Immun. 67:1505-1507.
51. Zughaier, S. M., H. C. Ryley, and S. K. Jackson. 1999. A melanin pigment purified from an epidemic strain of Burkholderia cepacia attenuates monocyte respiratory burst activity by scavenging superoxide union. Infect. Immun. 67:908-913.